{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3121"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3121","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"Ethical Oversight of Roles & Relationships in Treatment & Research in Advanced Disease States","abstract":"There is often ethical analysis focusing solely on the care of the patient by the physician or on the protection of the research participant by the clinical investigator, but those two are often overlapping. By paralleling the analysis of treatment and research, it emphasizes the specific ethical approaches necessary for individuals facing advanced diseases states in the separate roles of being a patient or participant. It also gives guidance to the complexity of the ethics surrounding medical professionals who float between the roles of treating physicians and clinical investigators. As individuals with advanced disease states are considered a vulnerable population due emotional and disease burden, the approach must be reanalyzed from initial diagnosis, during treatment, and at the end of life to reevaluate the most appropriate ethical approach for protection of the patient receiving treatment and the participant contributing to clinical research.","abstract_html":"There is often ethical analysis focusing solely on the care of the patient by the physician or on the protection of the research participant by the clinical investigator, but those two are often overlapping. By paralleling the analysis of treatment and research, it emphasizes the specific ethical approaches necessary for individuals facing advanced diseases states in the separate roles of being a patient or participant. It also gives guidance to the complexity of the ethics surrounding medical professionals who float between the roles of treating physicians and clinical investigators. As individuals with advanced disease states are considered a vulnerable population due emotional and disease burden, the approach must be reanalyzed from initial diagnosis, during treatment, and at the end of life to reevaluate the most appropriate ethical approach for protection of the patient receiving treatment and the participant contributing to clinical research.","abstract_has_math":false,"creators":["Vercelli, Alexa"],"institution":null,"degree_name":"PhD","degree_level":"One-year Embargo","degree_discipline":"Health Care Ethics","degree_department":null,"school":null,"contributors":["Gerard Magill","Joris Gielen","Peter Ikechukwu Osuji"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:51:57Z","subjects":["Treatment","Research","Advanced Disease","Ethics","Palliative Care","Bioethics and Medical Ethics"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/2193","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/2193","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3121","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Gerard Magill","Joris Gielen","Peter Ikechukwu Osuji"]},{"key":"dc:creator","label":"Author","values":["Vercelli, Alexa"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-09-21T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2022-08-13T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Health Care Ethics"]},{"key":"thesis:degree_level","label":"Degree Level","values":["One-year Embargo"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Treatment","Research","Advanced Disease","Ethics","Palliative Care","Bioethics and Medical Ethics"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/2193"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["There is often ethical analysis focusing solely on the care of the patient by the physician or on the protection of the research participant by the clinical investigator, but those two are often overlapping. By paralleling the analysis of treatment and research, it emphasizes the specific ethical approaches necessary for individuals facing advanced diseases states in the separate roles of being a patient or participant. It also gives guidance to the complexity of the ethics surrounding medical professionals who float between the roles of treating physicians and clinical investigators. As individuals with advanced disease states are considered a vulnerable population due emotional and disease burden, the approach must be reanalyzed from initial diagnosis, during treatment, and at the end of life to reevaluate the most appropriate ethical approach for protection of the patient receiving treatment and the participant contributing to clinical research."]},{"key":"dc:title","label":"Title","values":["Ethical Oversight of Roles & Relationships in Treatment & Research in Advanced Disease States"]}]}],"canonical_facts":{"dc:contributor":["Gerard Magill","Joris Gielen","Peter Ikechukwu Osuji"],"dc:creator":["Vercelli, Alexa"],"dc:date.available":["2023-09-21T07:00:00Z"],"dc:date.created":["2022-08-13T07:00:00Z"],"dc:description.abstract":["There is often ethical analysis focusing solely on the care of the patient by the physician or on the protection of the research participant by the clinical investigator, but those two are often overlapping. By paralleling the analysis of treatment and research, it emphasizes the specific ethical approaches necessary for individuals facing advanced diseases states in the separate roles of being a patient or participant. It also gives guidance to the complexity of the ethics surrounding medical professionals who float between the roles of treating physicians and clinical investigators. As individuals with advanced disease states are considered a vulnerable population due emotional and disease burden, the approach must be reanalyzed from initial diagnosis, during treatment, and at the end of life to reevaluate the most appropriate ethical approach for protection of the patient receiving treatment and the participant contributing to clinical research."],"dc:identifier":["https://dsc.duq.edu/etd/2193"],"dc:language":["English"],"dc:subject":["Treatment","Research","Advanced Disease","Ethics","Palliative Care","Bioethics and Medical Ethics"],"dc:title":["Ethical Oversight of Roles & Relationships in Treatment & Research in Advanced Disease States"],"thesis:degree_discipline":["Health Care Ethics"],"thesis:degree_level":["One-year Embargo"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:51:57Z"}